Senator the Hon. Mathias Cormann
Minister for Finance
Date: Wednesday, 19 November 2014
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Very strong demand from domestic and offshore institutional investors has led the Government to increase the indicative price range for the Medibank Private Share Offer.
The indicative price range was initially set at $1.55 to $2.00 per share.
Following strong interest from institutions, this has now been revised upwards to $2.00 to $2.30 per share.
The final price will not be determined until after the close of the Institutional Offer.
This will not impact the existing retail price cap that will ensure retail investors will pay no more than $2.00 per share, even if the institutional price is set above this level.1
No decisions will be made on the overall split of share allocations between the Retail and Institutional Offers, nor between domestic and offshore institutions, until the Share Offer has been completed.
The final price and the number of Medibank Private shares investors will receive, based on the allocation criteria, is expected to be announced by Tuesday, 25 November 2014.
Karen Wu – 0428 350 139
The Retail Offer of the Medibank Private Share Offer is now closed. The Commonwealth will not accept any further Applications under the Retail Offer. This document does not constitute an offer to sell, or a solicitation of an offer to buy securities in the United States. The shares referred to in this document have not been, and will not be, registered under the U.S. Securities Act of 1933 (the “U.S. Securities Act”) or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold in the United States absent registration under the U.S. Securities Act or an exemption from registration requirements.